1. Localized prostate cancer mortality remains similar between groups receiving prostatectomy, radiotherapy, or active monitoring. 2. About 25% of men...
1. Fewer instances of clinically insignificant prostate cancer were identified in an experimental group receiving prostate MRI and targeted biopsy...
1. Concurrent/adjuvant androgen-deprivation therapy has improved metastatic-free survival compared to neoadjuvant/concurrent androgen-deprivation therapy. 2. The statistical significance was mainly seen...
1. A retrospective analysis demonstrated that prostate-specific antigen (PSA) screening has overall declined in popularity in recent years. 2. Health...
1. In this randomized controlled trial, treatment of acute pyelonephritis and complicated urinary tract infection caused by gram-negative organisms with...
1. In a group of patients undergoing endoscopic removal of symptomatic kidney stones, concurrent removal of asymptomatic stones significantly reduced...
1. A combination of androgen deprivation therapy, docetaxel, and abiraterone (“triplet therapy”) had the best overall survival and progression-free survival...
1. Compared to intravenous ertapenem, oral tebipenem pivoxil hydrobromide was non-inferior in the treatment of complicated urinary tract infection and...
1. Bone mineral density testing was associated with a significant decreased risk of developing major osteoporotic fractures among older men...
1. Patients with hormone-sensitive prostate cancer receiving darolutamide, an androgen-receptor inhibitor, in addition to standard therapy demonstrated longer overall survival...
